6,500 Shares in Amedisys, Inc. (NASDAQ:AMED) Purchased by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS acquired a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 6,500 shares of the health services provider's stock, valued at approximately $590,000.

A number of other large investors also recently added to or reduced their stakes in AMED. Magnetar Financial LLC raised its stake in shares of Amedisys by 0.3% during the fourth quarter. Magnetar Financial LLC now owns 637,443 shares of the health services provider's stock worth $57,873,000 after buying an additional 1,835 shares during the last quarter. Xponance Inc. raised its position in shares of Amedisys by 3.5% during the 4th quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock valued at $395,000 after acquiring an additional 148 shares during the last quarter. Birnam Oak Advisors LP acquired a new position in shares of Amedisys in the 4th quarter valued at $15,832,000. Vestcor Inc acquired a new position in shares of Amedisys in the 4th quarter valued at $73,000. Finally, Swiss National Bank boosted its position in shares of Amedisys by 0.9% in the 4th quarter. Swiss National Bank now owns 64,400 shares of the health services provider's stock worth $5,847,000 after purchasing an additional 600 shares during the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Amedisys Trading Down 0.2 %

Shares of NASDAQ AMED traded down $0.19 during midday trading on Monday, reaching $91.70. 412,741 shares of the stock were exchanged, compared to its average volume of 398,362. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The company has a market capitalization of $3.01 billion, a price-to-earnings ratio of 36.39, a P/E/G ratio of 1.78 and a beta of 0.89. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The business has a 50-day simple moving average of $92.29 and a two-hundred day simple moving average of $92.21.

Remove Ads

Amedisys (NASDAQ:AMED - Get Free Report) last posted its earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $598.05 million for the quarter, compared to the consensus estimate of $602.38 million. As a group, equities research analysts expect that Amedisys, Inc. will post 4.4 EPS for the current year.

Analyst Ratings Changes

Separately, Stephens reiterated an "equal weight" rating and issued a $101.00 price objective on shares of Amedisys in a report on Tuesday, March 4th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $101.00.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.